All News

From chef Gordon Ramsay sharing a meal with a 13-year-old fan with Ewing sarcoma, to a dermatologist on a playground spotting a mother’s skin cancer, here’s a look at what’s happening in the cancer space this week.

City of Hope sets the bar for treating people, not just diseases.

Although she has always been driven to excel, Karen Driskill's, M.S., RN, purpose became more focused after her mother-in-law passed away from intrahepatic cholangiocarcinoma in 2010.

I’m not going to worry that I’m changing my own health by saying out loud that this cancer stuff is hard and scary and kills way too many people every single day.

The Food and Drug Administration granted a fast track designation to PDS0101 plus Keytruda for the treatment of patients with recurrent or metastatic HPV16-related head and neck cancer.

Watching my daughter’s life be interrupted by breast cancer made me want to help other parents who might find themselves in a similar situation.

If approved, Omblastys will be the first FDA-approved drug for children with neuroblastoma that has spread to the central nervous system or leptomeninges.

When I was diagnosed with metastatic breast cancer, my oncology nurse ended up becoming a trusted friend.

After I was diagnosed with cancer, I started to feel like a burden to my loved ones. So, I wrote a letter urging them to continue on with other aspects of their lives.

The FDA approval of Fylnetra, a biosimilar for Neulasta, has the potential to offer patients with cancer a neutropenia treatment option at a lower cost.

It’s good to have all the facts when you decide whether to participate in a cancer drug clinical trial—even the ones that make you swallow hard and tear up.

Research showed that Hispanic children with neuroblastoma who are participating on clinical trials tended to have worse survival outcomes than others.

The expertise, guidance and overall compassion of Katherine Caprinolo, B.S.N., RN have quite literally helped me survive these past two years.

My worst fear came true: I was diagnosed with COVID-19 while going through cancer. Now I live my life day by day.

A small percentage of patients with metastatic breast cancer participating in clinical trials in the U.S. are Black, which, according to a patient living with the disease is a huge concern since it doesn’t represent the general population.

In the immediate instance — and that’s where life is lived — I won’t spend my energy fighting against cancer. But that does not mean I don’t care. 

Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.

Both Opdivo plus Yervoy and Opdivo plus chemotherapy were approved by the Food and Drug Administration to treat patients with esophageal squamous cell carcinoma.

In a field populated by highly skilled and deeply compassionate nursing oncology professionals, Kathryn Buttner, B.S.N., RN, BMTCN, stands out, a co-worker said.

Through the support she provides, Stacey eases the load for patients with cancer and doctors alike.

Angela Joseph, RN, is compassionate to both patients with cancer and staffmembers.

I wish all patients had a nurse like Alyssa Johnson, M.S.N., RN.

Candise Jordan, FNP-BC, AONP, always knew that she was going to be a hematology/oncology nurse pratitioner.

Debbie Scoles, RN, has been a source of strength and hope for patients wit hcancer and colleagues alike.

Cheryl’s helpfulness in caring for her patients is very evident, as she is always using her spare time to make sure the patient is comfortable during their stay.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about genetics in women’s cancer.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about access to care in women’s cancer.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about survivorship in women’s cancer.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about maintaining a healthy lifestyle in women’s cancer.